The constant secretion of pro-angiogenic/pro-glycolytic growth factors such as vascular endothelial growth factor (VEGF) by tumor cells in combination with a hypoxic microenvironment generated by both tumor and stromal cells, modify the EC expression of glycolytic enzymes. Here, VEGFA is linked to neoplasm.